Human MAP2K3 Antibody : APC (Phospho-S189/S207)

Référence OAAQ00147-10tests

Conditionnement : 10Tests

Marque : Aviva Systems Biology

Contactez votre distributeur local :


Téléphone : +1 850 650 7790
Human MAP2K3 Antibody : APC (Phospho-S189/S207)

Human MAP2K3 Antibody : APC (Phospho-S189/S207) (OAAQ00147)

Datasheets/ManualsPrintable datasheet for OAAQ00147
Product Info
Tested Species ReactivityHuman, Mouse
Predicted Species ReactivityMouse, Rat
Product FormatLiquid. 1X PBS, 0.09% NaN3, 0.2% BSA.
ClonalityMonoclonal
CloneMKK3S189MKK6S207-D3
IsotypeRabbit IgG1k
HostRabbit
ConjugationAPC: Allophycocyanin
ApplicationFC
Reconstitution and Storage2-8C
ImmunogenA synthetic phospho-peptide corresponding to residues surrounding Ser189 of human phospho MKK3 and Ser207 of human phospho MKK6.
PurificationProtein A+G
Target Post-Translational ModificationPhospho-S189/S207
Application InfoFor flow cytometric staining, the suggested use of this reagent is 5 uL per million cells or 5 uL per 100 uL of staining volume. It is recommended that the reagent be titrated for optimal performance for each application.
Reference1. Derijard, B. et al. (1995) Science 267, 682-685.
2. Raingeaud, J. et al. (1995) J Biol Chem 270, 7420-6.
3. Sluss, H.K. et al. (1994) Mol. Cell. Biol. 14, 8376-8384.
4. Raingeaud, J. et al. (1996) Mol. Cell. Biol. 16(3), 1247-1255.
5. Han, J. et al. (1996) J. Biol. Chem. 271, 2886-2891.
Gene SymbolMAP2K3
Gene Full Namemitogen-activated protein kinase kinase 3
Alias SymbolsMEK3, MKK3, MAPKK3, PRKMK3, SAPKK2, SAPKK-2
NCBI Gene Id5606
Protein Namedual specificity mitogen-activated protein kinase kinase 3
Description of TargetThe protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene.
Uniprot IDP46734
Protein Accession #NP_001303261.1
Nucleotide Accession #NM_001316332.1